Enveric intends to immediately accelerate the development of a novel Psychedelic molecule for Cancer Related Distress NAPLES, Fla., Sept. 17, 2021 — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-centric biotechnology…
Read More
NAPLES, Fla., Sept. 9, 2021 — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced that…
Read More
Company has also released its second quarter and first half financial results for the period ended June 30, 2021 NAPLES, Fla., Aug. 18, 2021 — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a…
Read More
https://candidchronicle.com/enveric-enters-next-phase-of-cbd-cancer-treatment-trial/
Read More
Enveric Enters into Clinical Stage Development of Lead Asset, EV101, in Israel with MOH Approval NAPLES, Fla., July 8, 2021 — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-first biotechnology company developing…
Read More
https://www.youtube.com/watch?v=CDlMQVwiQNI
Read More
https://news.bloomberglaw.com/pharma-and-life-sciences/texas-the-latest-state-to-legalize-psychedelic-medical-research
Read More
https://www.youtube.com/watch?v=SENBJHkK0KE
Read More
https://www.benzinga.com/markets/cannabis/21/06/21433528/exclusive-magicmed-ceo-on-psychedelics-companys-secret-sauce-m-a-deal-with-enveric-biosciences
Read More
